Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS

Journal of Neuro-Oncology

Volumn 62, Issue 3, 2003, Pages 329-338

  Utriainen, Meri ^a   Komu, M ^a   Vuorinen, V ^a   Lehikoinen, P ^a   Sonninen, P ^a   Kurki, T ^a   Utriainen, T ^b   Roivainen, A ^a   Kalimo, H ^a   Minn, H ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

11C choline; Brain tumor; Nuclear magnetic resonance imaging; Positron emission tomography; Tumor metabolism

Indexed keywords

CARBON 11; CHOLINE; GADOLINIUM; INOSITOL;

ADULT; AGED; ARTICLE; BRAIN BIOPSY; BRAIN LEVEL; BRAIN LYMPHOMA; BRAIN METABOLISM; BRAIN REGION; BRAIN SURGERY; BRAIN TUMOR; CANCER GRADING; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MALE; METABOLITE; NON INVASIVE MEASUREMENT; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; THREE DIMENSIONAL IMAGING;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; CHOLINE; CONTRAST MEDIA; FEMALE; HUMANS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0038737148     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023342516925     Document Type: Article

References (33)

1. Brun H, Frahm J, Gyngell ML, Merboldt KD, Hänicke W, Sauter R, Hamburger C: Non-invasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: Initial experience in patients with cerebral tumors. Radiology 172: 541-548, 1989
2. Usenius JP, Kauppinen RA, Vainio PA, Hernesniemi JA, Vapalahti MP, Paljarvi LA, Soimakallio S: Quantitative metabolite patterns of human brain tumors: Detection by 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr 18: 705-713, 1994
3. Preul MC, Caramanos Z, Collins DL, Villemure JG, Leblanc R, Olivier A, Pokrupa R, Arnold DL: Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2: 323-325, 1996
4. Friedlund RP, Mathis CA, Budinger TF, Moyer BR, Rosen M: Labeled choline and phosphorylcholine: Body distribution and brain autoradiography: Concise communication. J Nucl Med 24: 812-815, 1983
5. 11C]choline; implications for in vitro imaging with positron emission tomography. Eur J Nucl Med 27: 25-32, 2000
6. Hara T, Kosaka N, Kishi H: PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 39: 990-995, 1998
7. Shinoura N, Nishijima M, Hara T, Haisa T, Yamamoto H, Fujii K, Mitsui I, Kosaka N, Kondo T: Brian tumors: Detection with C-11 choline PET. Radiology 202: 497-503, 1997
8. 11C]choline. J Nucl Med 38: 842-847, 1997
9. 18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest Radiol 22: 360-371, 1986
10. Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Moots PL, Kessler RM: Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195: 47-52, 1995
11. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 50: 1316-1322, 1998
12. Fulham MJ, Bizzi A, Dietz MJ, Shih HH, Raman R, Sobering GS, Frank JA, Dwyer AJ, Alger JR, Di Chiro G: Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance. Radiology 185: 675-686, 1992
13. Kleihues P, Cavenee WK: Pathology & Genetics of tumours of the nervous system. World Health Organization Classification of tumours. World Health Organization Classification of Tumours. IARC Press, Lyon, France, 2000
14. Patlak CS, Blasberg RG: Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5: 584-590, 1985
15. Hatazawa J, Ishiwata K, Masatoshi I, Kameyama M, Kubota K, Ido T, Matsuzawa T, Yoshimoto T, Watanuki S, Seo S: Quantitative evaluation of L-[Methyl-C-11] methionine uptake in tumor using positron tomography. J Nucl Med 30: 1809-1813, 1989
16. Ericson K, Blomqvist G, Bergström M, Eriksson L, Stone-Elander S: Application of a kinetic model on the methionine accumulation in intracranial tumours studied with positron emission tomography. Acta Radiologica 28: 505-509, 1987
17. Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE: Automated single-voxel proton MRS: Technical development and multisite verification. Mag Reson Med 31: 365-373, 1994
18. Probe Reconstruction and Quantitation Calculations. GE Medical Systems, Milwaukee, Wisconsin, 1998
19. Danielsen ER, Henriksen O: Absolute quantitative proton NMR spectroscopy based on the amplitude of the local suppression pulse. Quantification of brain water and metabolites. NMR Biomed 7: 311-318, 1994
20. Sallinen PK, Haapasalo HK, Visakorpi T, Helen PT, Rantala IS, Isola JJ, Helin HJ: Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA and S-phase fraction using archival paraffin-embedded samples. J Pathol 174: 275-282, 1994
21. Haapasalo HK, Sallinen PK, Helen PT, Rantala IS, Helin HJ, Isola JJ: Comparison of three quantitation methods for PCNA immunostaining: Applicability and relation to survival in 83 astrocytic neoplasms. J Pathol 171: 207-214, 1993
22. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, Di Chiro G: Increased choline signal coinciding with malignant degeneration of cerebral gliomas: A serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87: 516-524, 1997
23. Hwang JH, Egnaczyk GF, Ballard E, Dunn RS, Holland SK, Ball WS, Jr.: Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am J Neuroradiol 19: 535-540, 1998
24. Kinoshita Y, Yokota A: Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed 10: 2-12, 1997
25. Kuhlmann T, Schroter A, Dechent P, Weber F, Rustenbeck H, Fuzesi L, Bruck W, Ehrenreich H, Frahm J: Diagnosis of a multifocal B cell lymphoma with preceding demyelinating central nervous system lesions by single voxel proton MR spectroscopy. J Neurol Neurosurg Psychiatry 70: 259-262, 2001
26. Ohtani T, Kurihara H, Ishiuchi S, Saito N, Oriuchi N, Inoue T, Sasaki T: Brain tumor imaging with carbon-11 choline: Comparison with FDG PET and gadolium-enhanced MR imaging. Eur J Nucl Med 28: 1664-1670, 2001
27. 11C-methionine positron emission tomography. Cancer 95: 1376-1386, 2002
28. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, Shimosegawa E, Ito H, Hatazawa J, Okudera T, Uemura K, Yasui N, Mineura K: Cerebral glioma: Evaluation with methionine PET. Radiology 186: 45-53, 1993
29. Nuutinen J, Leskinen S, Lindholm P, Söderström KO, Någren K, Huhtala S, Minn H: Use of carbon-11 methionine positron emission tomography to assess malignancy grade and predict survival in patients with lymphomas. Eur J Nucl Med 25: 729-735, 1998
30. Haapasalo H, Sallinen S, Sallinen P, Helen P, Jaaskelainen J, Salmi TT, Paetau A, Paljarvi L, Visakorpi T, Kalimo H: Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomas. Neuropathol Appl Neurobiol 25: 134-142, 1999
31. Rhodes RH: Biological evaluation of biopsies from adult cerebral astrocytomas: Cell-growth/cell-suicide ratios and their relationship to patient survival. J Neuropathol Exp Neurol 57: 746-757, 1998
32. Ho DM, Wong TT, Hsu CY, Ting LT, Chiang H: MIB-1 labeling index in nonpilocytic astrocytoma of childhood: A study of 101 cases. Cancer 82: 2459-2466, 1998
33. Miyagawa T, Oku T, Uehara H, Desai R, Beattie B, Tjuvajev J, Blasberg R: Facilitated amino acid transport is upregulated in brain tumors. J Cereb Blood Flow Metab 18: 500-509, 1998